What You Should Know:
– GE HealthCare (Nasdaq: GEHC) and Biofourmis announced a strategic collaboration today, aiming to revolutionize patient care by enabling safe and effective care at home.
– The strategic partnership leverages the expertise of both companies to deliver innovative care-at-home solutions, improving patient experiences and addressing healthcare system challenges.
– GE HealthCare will begin distributing Biofourmis solutions to customers in the United States starting Q1 2024.
Addressing Healthcare System Challenges
Healthcare systems face rising costs due to factors like staff shortages, limited bed capacity, and high readmission rates. Care-at-home programs, often incorporating virtual components, have proven effective in reducing hospital stays and readmissions, leading to potential cost savings. These programs also contribute to patient recovery and safety by potentially reducing falls and hospital-acquired infections. Studies show patients using remote solutions experience a higher level of satisfaction with their overall care.
Enhancing Patient Care with Remote Monitoring:
This collaboration aims to:
– Facilitate earlier discharge: Enable more patients to return home sooner, providing comfort and peace of mind while receiving high-quality care.
– Offer alternatives to facility-based care: Provide options beyond traditional hospitalization.
– Promote healthy behaviors: Encourage patients to manage their health effectively at home.
– Deliver personalized care: Utilize Biofourmis’ FDA-cleared, AI-guided algorithms to provide care teams with valuable insights for individual patients.
“Biofourmis’ demonstrated success with care-at-home solutions will extend GE HealthCare’s current inpatient monitoring portfolio to support patient care from the hospital to home,” said Ashutosh Banerjee, GE HealthCare. “Combining our companies’ demonstrated capabilities will help revolutionize the way we approach the patient care journey as well as help address current challenges faced by health systems including hospital capacity issues and clinical staffing shortages.”
